Indolent mantle-cell lymphoma: Immunoglobulin variable region heavy chain sequence analysis reveals evidence of disease 10 years prior to symptomatic clinical presentation

Journal of Clinical Oncology

Volumn 29, Issue 15, 2011, Pages

  Rule, Simon A J ^a   Poplar, Sarah ^a   Evans, Paul A S ^b   O'Connor, Sheila J M ^b   Owen, Roger G ^b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b ST JAMES S INSTITUTE OF ONCOLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; B LYMPHOCYTE; CANCER INFILTRATION; CANCER REGRESSION; CASE REPORT; CELL POPULATION; DUODENUM DISEASE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN VARIABLE REGION; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; SEQUENCE ANALYSIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

DELAYED DIAGNOSIS; DUODENAL DISEASES; EMERGENCY TREATMENT; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; INTESTINAL PERFORATION; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; SEQUENCE ANALYSIS, DNA; TRANSLOCATION, GENETIC;

EID: 79957437578     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.8006     Document Type: Article

References (22)

1. Berger F, Felman P, Sonet A, et al: Nonfollicular small B-cell lymphomas: A heterogeneous group of patients with distinct clinical features and outcome. Blood 83:2829-2835, 1994 (Pubitemid 24142713)
2. Samaha H, Dumontet C, Ketterer N, et al: Mantle cell lymphoma: A retrospective study of 121 cases. Leukemia 12:1281-1287, 1998 (Pubitemid 28395993)
3. Romaguera JE, Medeiros LJ, Hagemeister FB, et al: Frequency of gastrointestinal involvement and its clinical significance in mantle cell lymphoma. Cancer 97:586-591, 2003 (Pubitemid 36125835)
4. Yoong Y, Kurtin PJ, Allmer C, et al: Efficacy of splenectomy for patients with mantle cell non-Hodgkin's lymphoma. Leuk Lymphoma 42:1235-1241, 2001 (Pubitemid 34082910)
5. Angelopoulou MK, Siakantariz MP, Vassilakopoulos TP, et al: The splenic form of mantle cell lymphoma. Eur J Haematol 68:12-21, 2002 (Pubitemid 34407538)
6. Ruchlemer R, Wotherspoon AC, Thompson JN, et al: Splenectomy in mantle cell lymphoma with leukaemia: A comparison with chronic lymphocytic leukaemia. Br J Haematol 118:952-958, 2002 (Pubitemid 35025956)
7. Martin P, Chadburn A, Christos P, et al: Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol 27:1209-1213, 2009
8. Eve HE, Furtado MV, Hamon MD, et al: Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphoma. J Clin Oncol 27:e189-e190, 2009
9. Orchard J, Garand R, Davis Z, et al: A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 101:4975-4981, 2003 (Pubitemid 36857762)
10. Matutes E, Parry-Jones N, Brito-BabapulleV, et al: The leukemic presentation of mantle-cell lymphoma: Disease features and prognostic factors in 58 patients. Leuk Lymphoma 45:2007-2015, 2004 (Pubitemid 39232849)
11. Molina TJ, Delmer A, Cymbalista F, et al: Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly: A report of eight cases with similar clinical presentation and aggressive outcome. Virchows Arch 437:591-598, 2000 (Pubitemid 32003088)
12. Oinonen R, Franssila K, Elonen E: Spontaneous splenic rupture in two patients with a blastoid variant of mantle cell lymphoma. Ann Hematol 74:33-35, 1997 (Pubitemid 27050907)
13. Hoster E, Dreyling M, Klapper W, et al: A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111:558-565, 2008
14. Rosenwald A, Wright G, Wiestner A, et al: The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3:185-197, 2003 (Pubitemid 37443390)
15. Tiemann M, Schrader C, Klapper W, et al: Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): A clinicopathological study from the European MCL Network. Br J Haematol 131:29-38, 2005 (Pubitemid 43899705)
16. Bertoni F, Conconi A, Cogliatti SB, et al: Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: A study of the Swiss Group for Clinical Cancer Research. Br J Haematol 124:289-298, 2004 (Pubitemid 38167978)
17. Cogliatti SB, Bertoni F, Zimmermann DR, et al: IgV H mutations in blastoid mantle cell lymphoma characterize a subgroup with a tendency to more favourable clinical outcome. J Pathol 206:320-327, 2005 (Pubitemid 40903196)
18. Lai R, Lefresne SV, Franko B, et al: Immunoglobulin VH somatic hypermutation in mantle cell lymphoma: Mutated genotype correlates with better clinical outcome. Mod Pathol 19:1498-1505, 2006 (Pubitemid 44624170)
19. Camacho FI, Algara P, Rodríguez A, et al: Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood 101:4042-4046, 2003 (Pubitemid 36857884)
20. Kienle D, Kröber A, Katzenberger T, et al: VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: Correlation with genomic aberrations, clinical characteristics, and outcome. Blood 102:3003-3009, 2003 (Pubitemid 37248876)
21. Schraders M, Oeschger S, Kluin PM, et al: Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity. Mod Pathol 22:416-425, 2009
22. Fernàndez V, Salamero O, Espinet B, et al: Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma. Cancer Res 70:1408-1418, 2010